[Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]

H Wang1, B Lai, J Li

  • 1Cellular and Molecular Biology Lab, Beijing Thoracic Tumor Research Institute, Beijing 101149.

Abstract

Insights

Introducing wild type p53 suppressor gene into human lung cancer cells with mutant p53 significantly inhibited tumor growth in vitro and in vivo. This suggests gene therapy with wild type p53 may be effective for lung cancer treatment.

Area of Science:

  • Molecular biology
  • Cancer genetics
  • Gene therapy

Context:

  • The p53 tumor suppressor gene plays a critical role in preventing cancer.
  • Mutations in the p53 gene are common in many human cancers, including lung cancer.
  • Restoring wild type p53 function is a potential therapeutic strategy.

Purpose:

  • To investigate the effects of introducing an exogenous wild type p53 gene into a human lung cancer cell line harboring a mutant p53 gene.
  • To assess the impact on malignant growth both in vitro and in vivo.

Summary:

  • Human lung cancer cell line 801-D with a mutant p53 gene was transfected with a plasmid expressing wild type p53.
  • The transfected cell line (801-D-p53) exhibited significantly inhibited growth in vitro, with a 96% reduction in colony formation.
  • In vivo studies showed suppressed tumorigenicity in nude mice, with reduced tumor incidence and volume compared to control groups.

Impact:

  • Stable expression of exogenous wild type p53 suppressed malignant proliferation of lung cancer cells.
  • These findings support the potential of gene therapy using wild type p53 for treating human lung cancer.